Myocardial T1 and extracellular volume fraction mapping at 3 tesla by Lee, Jason J et al.
TECHNICAL NOTES Open Access
Myocardial T1 and Extracellular Volume Fraction
Mapping at 3 Tesla
Jason J Lee
1, Songtao Liu




1, Christopher T Sibley
1,2,
Peter Kellman
3, Andrew E Arai
3 and David A Bluemke
1,2*
Abstract
Background: To compare 11 heartbeat (HB) and 17 HB modified lock locker inversion recovery (MOLLI) pulse
sequence at 3T and to establish preliminary reference values for myocardial T1 and the extracellular volume
fraction (ECV).
Methods: Both phantoms and normal volunteers were scanned at 3T using 11 HB and 17 HB MOLLI sequence
with the following parameters: spatial resolution = 1.75 × 1.75 × 10 mm on a 256 × 180 matrix, TI initial = 110 ms,
TI increment = 80 ms, flip angle = 35°, TR/TE = 1.9/1.0 ms. All volunteers were administered Gadolinium-DTPA
(Magnevist, 0.15 mmol/kg), and multiple post-contrast MOLLI scans were performed at the same pre-contrast
position from 3.5-23.5 minutes after a bolus contrast injection. Late gadolinium enhancement (LGE) images were
also acquired 12-30 minutes after the gadolinium bolus.
Results: T1 values of 11 HB and 17 HB MOLLI displayed good agreement in both phantom and volunteers. The
average pre-contrast myocardial and blood T1 was 1315 ± 39 ms and 2020 ± 129 ms, respectively. ECV was stable
between 8.5 to 23.5 minutes post contrast with an average of 26.7 ± 1.0%.
Conclusion: The 11 HB MOLLI is a faster method for high-resolution myocardial T1 mapping at 3T. ECV fractions
are stable over a wide time range after contrast administration.
Background
Cardiovascular magnetic resonance (CMR) is a noninva-
sive imaging method for accurate assessment of myocar-
dial anatomy and function. A unique feature of CMR is
the ability to use the proton relaxation times, such as
T1, T2, and T2*, to characterize myocardial or vascular
tissue [1]. These values are largely dependent on the
physical and chemical environments of water protons in
the tissue. Myocardial fibrosis is one of the most com-
mon histological features of the failing heart [2]. Late
gadolinium enhancement (LGE) has been the standard
of reference for detecting focal myocardial fibrosis in
clinical practice [3]. LGE relies on the differences in sig-
nal intensity between scarred and adjacent normal myo-
cardium to generate image contrast. Because this
method lacks a normal myocardium reference value,
LGE is unlikely to detect the presence of diffuse
myocardial fibrosis tissue. T1 mapping, is a promising
quantitative method for detecting diffuse myocardial
fibrosis.
The Modified Look-Locker Inversion-recovery
(MOLLI) technique uses electrocardiogram (ECG)-gated
image acquisition at end-diastole and merges images
from multiple consecutive inversion-recovery experi-
ments into one data set. A high-resolution T1 map of
the myocardium can be acquired in one breath hold
[4,5]. The traditional MOLLI protocol uses three inver-
sion-recovery blocks to acquire 11 images over 17 heart-
beats (HB). These longer breath holds may limit its
clinical applications in patients with impaired respiratory
conditions due to cardiac diseases. Several new proto-
cols have been proposed to reduce the MOLLI acquisi-
tion time [6,7].
Post contrast myocardial T1 values are affected by a
variety of factors. These include, but are not limited to,
the type and amount of gadolinium contrast injected,
post contrast scan times, renal function, hematocrit, Bo
field, body composition, as well as pre-contrast T1 time.
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Normalizing myocardial T1 in relationship to blood T1
avoids much of these complexities. Extracellular volume
fraction (ECV), fibrosis index [9], or volume of distribu-
tion [10,11] are similar methods that measure the myo-
cardial extracellular volume fraction by normalizing
myocardial R1 change with blood R1 change and by cor-
rection for hematocrit. Although previous studies show
that myocardial ECV quantifications correlate with dif-
fuse myocardial fibrosis [10,12], these values have not
yet been reported for 3T CMR.
In this study, we evaluated the accuracy of the 11 HB
and 17 HB MOLLI sequences at 3T through phantom
and normal volunteer studies. Preliminary reference
values of both pre-contrast and post-contrast were
quantified at different time points. Additionally, preli-
minary reference ECV values were also estimated from
the normal volunteers.
Methods
All experiments were performed at a 3 Tesla scanner
(Verio, Siemens Medical Systems, Erlangen, Germany)
with a 32-channel cardiovascular array coil (Invivo,
Orlando, FL).
I. CMR parameters
The 17 HB MOLLI consists of three inversion blocks: 3
images are acquired after each of the first two inversion
pulses and 5 images are acquired after the third inversion
pulse. The 11 HB MOLLI consists of 2 inversion blocks:
3 images are acquired after the first inversion pulse and 5
images are acquired after the second inversion pulse.
Both the 17 HB and 11 HB protocol share all other para-
meters: 3 heartbeat pause between inversion blocks, non-
segmented steady state free precession readout, field of
view: 360 × 290 mm, matrix: 256 × 180, slice thickness
10 mm, TR/TE: 1.9/1.0 ms, minimum inversion time 110
ms, inversion time increment 80 ms, flip angle 35
degrees, GRAPPA parallel imaging factor 2.
II. Phantom Studies
The phantoms containing agarose gel doped with cupric
sulfate were scanned using both 17 HB and 11 HB
MOLLI sequence with simulated heart rates from 40 to
110 beats per minute (BPM) in increments of 10 heart-
beats. To determine the reference T1 time of each phan-
tom, standard inversion-recovery spin echo sequence
w i t ht h es a m eF O Va n dm a t r i xs i z ew e r ea c q u i r e da t2 0
different TIs with a TR of 10 sec, and a TE of 8.5 ms.
III. Human Volunteer Studies
Eleven healthy human subjects (six male and five female,
ages 36 ± 13 years) without cardiovascular disease were
enrolled for this study. All participants have normal
ECG and were briefed on the procedure they were to
undertake and all volunteers gave institutional review
board approved written informed consent. 11 HB and
17 HB MOLLI images were acquired at mid-ventricular
s h o r ta x i sv i e w .A l ls u b j e c t sw e r ea d m i n i s t e r e dG a d o l i -
nium-DTPA contrast (Magnevist, 0.15 mmol/kg) at an
injection rate of 2 ml/s followed by a 20 ml saline flush.
Multiple post-contrast MOLLI scans were performed at
t h es a m ep r e - c o n t r a s tp o s i t i o nf r o m3 . 5 ,5 ,8 . 5 ,1 3 . 5 ,
18.5 and 23.5 minutes after contrast injection. Standard
phase sensitive inversion recovery late gadolinium
enhancement imaging was acquired at 12-30 minutes
after contrast injection [13]. Blood samples were taken 1
to 4 hours prior to the CMR scan to determine the
hematocrit and creatinine.
IV. Image Analysis
For both phantom and human studies, T1 maps were
calculated using MRmap [14] and stored in Digital Ima-
ging and Communications in Medicine (DICOM) For-
mat. To extract myocardial T1 values for the human
subjects, endocardial and epicardial contours were
manually traced using QMass MR 7.2 (Leiden, Nether-
lands). The blood pool regions were carefully excluded
when the regions of interest were traced. Phantom
MOLLI T1 values of different heart rates were fitted to
IR-SE T1 values by 2
nd order polynomial function and
pre-contrast in-vivo MOLLI T1 values were corrected
according to the phantom result. ECV values were cal-
culated using [11]:
 R1myo =1 / T 1 myo−post − 1/T1myo−pre
 R1blood =1 / T 1 blood−post − 1/T1blood−pre
ECV =  R1myo/ R1blood × (100 − HCT)
where ECV and HCT are give as percentage.
V. Data Analysis
Statistical analyses were performed using SAS 9.1(Cary,
North Carolina, USA) and Medcalc 11.6 (Medcalc
Software, Belgium). Bland-Altman plots were used to
describe the difference of T1 values between 17 HB
and 11 HB protocols. To statistically compare the T1
values of two protocols, a general linear mixed model
was used. The MOLLI protocol was included in the
model as a fixed effect, while the phantom was
included as a random effect. Similarly, all pre- and
post-contrast 17 HB MOLLI T1, 11 HB MOLLI T1 as
well as all ECV values quantified from volunteer data
were also compared using a general linear mixed
model. This model included time and the MOLLI pro-
tocols as fixed effects and the patients as random
effect. The recovery rates of both the myocardial and
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Patrick Royston’sp - t r e n dt e s t .
Results
I. Phantom
Both 11 HB and 17 HB MOLLI results were similar to
IR-SE T1 values up to ~500 ms but both sequences
underestimated T1 time for values > 500 ms. This
underestimation was non linear and increased with
higher heart rates. The 17 HB MOLLI acquires 11
images whereas the 11 HB MOLLI acquires 8 images.
By comparing both sequences, the 11 HB MOLLI has a
predicted noise penalty of 17% compared to the 17 HB
MOLLI (

(11/8)). Comparing both sequences, the
acquisition time was reduced by 35% when using the 11
HB MOLLI. Figure 1 and 2 respectively display the 17
HB and 11 HB MOLLI results compared to IR-SE.
There was no significant difference between the 11 HB
and 17 HB MOLLI (p = 0.82) by the general linear
mixed model. A Bland-Altman plot comparing the two
sequences at 60 bpm is presented in Figure 3 and dis-
plays a mean difference of 0.45 ± 1.96%. There is no sig-
nificant bias and no relationship between the magnitude
of T1 and error.
II. Volunteers
All volunteers had normal renal function (eGFR: 108 ±
17 ml/min/1.73 m
2) and no focal myocardial scars were
detected on the LGE images. The pre- and post-contrast
MOLLI images were all interpretable for T1 mapping
and contained little to no artifacts. Figure 4 shows a
mid-ventricular short axis T1 map for pre- and post-
contrast. There was no significant difference between 11
HB and 17 HB MOLLI in volunteers (p = 0.41) by the
general linear mixed model. All values reported in this
s t u d yw e r et h e r e f o r eb a s e do n measurements acquired
using the 11 HB MOLLI only.
T1 values are field strength dependent and increase
with field strength [15]. The mean pre-contrast T1
values of myocardium and blood were 1315 ± 39 ms
Figure 1 Phantom Study. 17 HB MOLLI sequences progressively underestimated T1 compared to IR-SE in phantoms as T1 and heart rate
increased.
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cardium and blood T1 plot is presented in Figure 5.
This plot demonstrates that gadolinium contrast is at
dynamic equilibrium between myocardium and blood
pool where their respective T1 values are recovering at
a similar rate from 3.5 to 23.5 minutes (p = 0.86).
ECV was calculated at all post contrast time points by
normalizing myocardial R1 change with blood R1
change and also correcting for hematocrit. Figure 6 dis-
plays the mean ECV values for each post-contrast time
interval. There was no significant difference between 11
HB and 17 HB ECV in volunteers (p = 0.35). In addi-
tion, there is no significant difference of ECV after 8.5
minutes (p = 0.10). The least square mean of ECV
between 8.5 minutes and 23.5 minutes was 26.7 ± 1.0%.
A Bland-Altman plot comparing the two sequences for
all ECV values is presented in Figure 7.
Table 1 display myocardial and blood pool T1 values
as well as myocardial ECV values using both the 17
HB and 11 HB MOLLI sequences. The standard
deviations (SD) for all T1 and ECV values are also
presented.
Discussion
The MOLLI sequence has been demonstrated to be an
accurate and reproducible approach for myocardial T1
mapping [4,5]. The originally described MOLLI protocol
requires a 17 heartbeat breath hold. A breath hold dura-
tion of 17 heart beats is difficult to achieve for older
subjects and patients with impaired cardiovascular or
pulmonary function. In this study, we compared a two
inversion-recovery block 11 heartbeat MOLLI with the
classic three inversion-recovery block 17 heartbeat
MOLLI. With a 35% reduction in acquisition time, the
11 HB MOLLI achieved excellent agreement with the 17
HB MOLLI over a wide range of T1 times in our phan-
tom study. There was no statistical difference between
the two protocols for normal subjects for both pre-con-
trast and a series of post-contrast time points at 3T.
The 11 HB MOLLI protocol is easy to implement on
Figure 2 Phantom Study. 11 HB MOLLI sequences progressively underestimated T1 compared to IR-SE in phantoms as T1 and heart rate
increased.
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cessing software. Both the 11 HB MOLLI and 17 HB
MOLLI exhibited a systemic, nonlinear heart rate
dependency of longer T1 values [5]. The observed devia-
tion in measured versus actual T1 with lengthening T1
and shortened RR interval is as expected and does not
display an inconsistent relationship. A heart rate correc-
tion of pre-contrast myocardial and blood T1 values is
thereby recommended at 3 Tesla. Compared to shorter
(and accurate) post-contrast T1’s, the longer (and
inaccurate) pre-contrast T1 times translated to R1 (1/
T1) have less effect on the ECV.
For T1 mapping to be a routine clinical tool, the 17
HB MOLLI protocol must have a significantly reduced
acquisition time. Piechnik et al [6] proposed a 9 heart-
beat shortened MOLLI (shMOLLI). Their sequence is a
3 inversion-recovery block scheme that collects 7 images
in 9 heartbeats. Because of the insufficient magnetiza-
tion recovery of the last 2 inversion-recovery blocks, the
l a s t2i m a g e sw e r eo n l yu s e dt of i tt h es h o r tT 1t i m e s
Figure 3 Phantom Study. Bland-Altman Plot comparing 17 HB MOLLI and 11 HB MOLLI T1 values at 60 bpm.
Figure 4 Human Study. Mid-ventricular short axis T1 maps. From left to right: pre-contrast, 5 minutes, 8.5 minutes, 13.5 minutes, 18.5 minutes
and 23.5 minutes post-contrast. All images were displayed with same setting.
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results displayed good correlation with T1 times less
than 800 ms, longer T1 times were underestimated
about 4%.
Imaging at 3T has become the standard for neurologi-
cal and musculoskeletal imaging. Cardiac imaging has
been slow to adopt 3T imaging because of the inhomo-
geneities of both static magnetic field (B0) and the trans-
mit radiofrequency field (B1) [16]. With the recent
technological development of parallel radiofrequency
transmission [17] as well as improved shimming algo-
rithms [18], 3T scanners have been a more viable option
for cardiac imaging because of the improvements in sig-
nal-to-noise ratio.
Compared to limited literature reports, the pre-con-
trast blood T1 values measured in our study (2020 ms)
showed similar mean values with the results presented
in a study conducted by Stanisz et al [19] (1932 ms). In
contrast, the results for both these studies are signifi-
cantly longer than the results of studies conducted by
Sharma et al [20] (1670 ms) and Noeske et al [16] (1550
ms). This difference can be attributed to the limited
range of TI values for these studies (100-800 ms and
500-1500 ms, respectively). The pre contrast blood T1
values from our data are about 26% to 38% longer than
those of 1.5T results. For pre-contrast myocardial T1
times, our results (1315 ms) are shorter than those
obtained by Stanisz et al [19] (1471 ms), but longer
than the results acquired by Piechnik et al [6] (1169
ms), Sharma et al [20] (1200 ms) and Noeske et al [16]
(1115 ms). Compared to previous myocardial T1 data at
1.5T, the pre-contrast myocardial T1 at 3T are 22% to
33% greater.
Pre-contrast T1s are longer at 3T and may not fully
recover when the same sampling schemes are used as
for 1.5T. A study conducted by Schelbert et al [7] intro-
duced a hybrid MOLLI protocol adapted to the
expected pre-contrast or post-contrast T1 values. At
1.5T, longer pre-contrast T1 times used a 2 inversion-
recovery block scheme that collects 6 images. The
shorter post-contrast T1 times used a 3 inversion-recov-
ery block scheme that collects 7 images to cover for
Figure 5 Human Study. Recovery of absolute myocardial and blood T1 from 3.5 minute to 23.5 minutes after 0.15 mmol/kg of Gd-DTPA.
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scans were acquired in 11 HB. The hybrid MOLLI exhi-
bits less bias and better agreement with the classic 17
HB MOLLI gold standard values at 1.5T. Breton et al
[21] proposed a two heart beat saturation recovery T1
mapping technique. By acquiring a proton density image
and a 500 ms saturation recovery image, T1 maps were
generated by solving the Bloch equation. Although this
method has very high acquisition speeds which effec-
tively eliminate cardiac motion artifacts, it suffers from
limited spatial resolution and limited T1 accuracy.
Extracellular volume fraction (ECV) [22,23], volume of
distribution (Vd)[10], fibrosis index [24], and volume
fraction of extravascular extracellular matrix (Ve) [7] all
share the same parameters for measuring the myocardial
extracellular matrix by adjusting the gadolinium contrast
partition coefficient with the patient’sh e m a t o c r i t .A
study conducted by Kehr et al [24] demonstrated that
gadolinium distribution volume is closely correlated
with histological collagen volume fraction (CVF) in
vitro. Messroghli et al [12] recently reported there is a
moderate correlation (r = 0.69) between CMR ECV and
histological collagen volume fraction in a small animal
model of left ventricular hypotrophy.
To accurately quantify ECV, steady state equilibrium
of gadolinium chelates must be reached between the
plasma and myocardial interstitium. Following an intra-
venous injection, gadolinium chelates such as Gd-DTPA
are continuously cleared from the blood via renal clear-
ance. After an initial period of equilibration, the contrast
agent concentration in the blood will steadily decrease
over time. However, if the contrast exchange rate
between blood and tissue is faster than the renal clear-
ance, then the ratio of contrast agent concentration
between tissue and blood will, after the short initial
equilibration period, achieve a dynamic equilibrium over
a certain time [11], (Ugander et al, Extracellular volume
imaging by MRI provides insig h ti n t oo v e r ta n ds u b c l i -
nical myocardial pathology, in press). F l e t te ta l[10]
developed the equilibrium contrast CMR method (EQ-
CMR), by administering contrast via bolus injection fol-
lowed by a slow continuous infusion. Their results
Figure 6 Human Study. Average ECV fractions of post-contrast times for both 17 HB MOLLI and 11 HB MOLLI.
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tological CVF in aortic stenosis and hypertrophic cardio-
mypathy. However, longer infusion methods are difficult
to incorporate into clinical CMR workflow. A previous
study completed by S c h e l b e r te ta l[7] validated the
bolus technique as an equally accurate method as the
slow infusion technique for quantifying ECV. We have
verified this dynamic equilibrium in normal volunteer at
3T by repeatedly measuring both myocardial and blood
T1 at different time points. In certain pathological
situations, such as the microvasular obstruction, the
assumption of dynamic equilibrium is not valid.
Our study used the bolus injection technique. General
linear mixed model demonstrated that there is no statisti-
cal difference of ECV values from 8.5 minutes. Between
8.5 to 23.5 minutes, the ECV differences between consecu-
tive time points were less than 3%. This difference is sig-
nificantly less than the coefficient of variation for our
average ECV value. Compared to previous reports, our
results suggest that the gadolinium concentration could
Figure 7 Human Study. Bland-Altman plot comparing all 17 HB MOLLI and 11 HB MOLLI ECV.
Table 1 Myocardial and blood pool T1 as well as myocardial ECV values using both the 17 HB and 11 HB MOLLI
sequences at different time points (Average ± standard deviation)
Structure Sequence Pre-Contrast Post 3.5 min Post 5 min Post 8.5 min Post 13.5 min Post 18.5 min Post 23.5 min
Myocardium T1 (ms) 17 HB MOLLI 1,324 ± 48 426 ± 44 476 ± 42 526 ± 31 583 ± 43 622 ± 40 661 ± 38
Myocardium T1 (ms) 11 HB MOLLI 1,314 ± 39 441 ± 50 467 ± 43 537 ± 52 583 ± 48 619 ± 48 659 ± 52
Blood pool T1 (ms) 17 HB MOLLI 2,037 ± 152 246 ± 33 282 ± 38 331 ± 37 384 ± 38 433 ± 42 462 ± 41
Blood pool T1(ms) 11 HB MOLLI 2,020 ± 128 255 ± 39 269 ± 22 337 ± 43 390 ± 44 429 ± 39 469 ± 42
Myocardium ECV (%) 17 HB MOLLI N/A 25.5 ± 4.1 26.4 ± 3.8 26.5 ± 3.8 27.3 ± 4.2 26.1 ± 3.4 26.3 ± 3.8
Myocardium ECV (%) 11 HB MOLLI N/A 24.2 ± 3.8 25.7 ± 3.8 26.5 ± 4.4 27.2 ± 4.6 26.7 ± 3.9 25.8 ± 4.1
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dium as early as 8.5 minutes. Combining our results with
those of Schelbert et al [7], ECV is stable in normal volun-
teers from 8.5 to 50 minutes after bolus contrast injection.
Our findings permit considerable flexibility for incorporat-
ing ECV into routine CMR work flow. A limitation of
both this study and Schelbert’s study is that there is a lack
of substantial data for subjects with cardiac disease. Dis-
eased subjects may have areas of severe fibrosis/scarring
or cardiac dysfunction. Either of these conditions could
delay the time to reach steady-state equilibrium. Further
testing in patients with severe fibrosis and reduced ejec-
tion fraction should be done to verify whether continuous
infusions can be fully replaced by the single-bolus
approach in clinical settings.
T1 values are affected by confounding variables such
as field strength, gadolinium contrast type and dose,
scanning time and the patient’s renal function. Due to
these factors, T1 times cannot be readily compared to
T1 data from other centers. In contrast, ECV is an
inherent physiological property that should not be
affected by these variables. The ECV data of normal
volunteers from our study at 3T (26.7%) slightly higher
than the “fibrosis index” of normal volunteers reported
by Broberg et al [9] (24.8%) and the Ve quantified by
Schelbert et al [7] after the Ve value was converted into
comparable ECV values (24.1%). The higher ECV seen
in this study might be an effect of relatively stronger
shortening of the longer pre-contrast blood T1 at 3T as
compared to that at 1.5 T. In addition, Both Broberg
and Schelbert’s study used protocols significantly differ-
ent from the protocol used in our study.
Conclusions
In conclusion, we have validated MOLLI sequences at
3T in phantom studies. We present values for myocar-
dial and blood T1 pre and post gadolinium contrast at
3T. At 3T, post-gadolinium ECV is stable between 8.5
and 23.5 minutes after gadolinium injection.
Limitations
There are several limitations to this study. This studied
had a small number of subjects with varying ages and
genders. Only a single contrast agent was used for this
study. There is no direct comparison to EQCMR or
ShMOLLI. There is no repeatability analysis with intra
and inter-observer variability. Only the mid-cavity ven-
tricular slice was taken and the mean T1 for the entire
myocardium was used. There may be some variations in
T1 and ECV in the basal, apical, septal and lateral walls.
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